Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: Preliminary results of a prospective study

Journal of Thoracic and Cardiovascular Surgery

Volumn 123, Issue 3, 2002, Pages 466-474

  Ahrendt, Steven A ^a   Yang, Stephen C ^b   Wu, Li ^b   Roig, Carmen M ^b   Russell, Pamela ^b   Westra, William H ^b   Jen, Jin ^b   Brock, Malcolm V ^b   Heitmiller, Richard F ^b   Sidransky, David ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; ONCOGENE K RAS; PRIORITY JOURNAL;

EID: 18544386726     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2002.120343     Document Type: Article

References (29)

1. Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111:1710-7.
2. Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med. 1995;332:429-35.
3. Maruyama R, Sugio K, Mitsudomi T, Saitoh G, Ishida T, Sugimachi K. Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage I non-small-cell lung cancer. J Thorac Cardiovasc Surg. 1997;114:535-43.
4. Chen ZL, Perez S, Holmes EC, Wang HJ, Coulson WF, Wen DR, et al. Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma. J Natl Cancer Inst. 1993;85:493-8.
5. Passlick B, Izbicki, JR, Kubuschok B, Nathrath W, Thetter O, Pichlmeier U, et al. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer. J Clin Oncol. 1994;12:1827-32.
6. Kubuschok B, Passlick B, Izbicki JR, Thetter O, Pantel K. Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small cell lung cancer. J Clin Oncol. 1999; 17:19-24.
7. Dobashi K, Sugio K, Osaki T, Oka T, Yasumoto K. Micrometastatic p53-positive cells in the lymph nodes of non-small-cell lung cancer: prognostic significance. J Thorac Cardiovasc Surg. 1997;114:339-46.
8. Goldstein NS, Mani A, Chmielewski G, Welsh R, Pursel S. Immunohistochemically detected micrometastases in peribronchial and mediastinal lymph nodes from patients with T1, N0, M0 pulmonary adenocarcinomas. Am J Surg Pathol. 2000;24:274-9.
9. Ahrendt SA, Yang SC, Wu L, Westra WH, Jen J, Califano JA, et al. Comparison of oncogene mutation detection and telomerase activity for the molecular staging of non-small cell lung cancer. Clin Cancer Res. 1997;3:1207-14.
10. Nelson HH, Christiani DC, Mark EJ, Wiencke JK, Wain JC, Kelsey KT. Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. J Natl Cancer Inst. 1999;91:2032-8.
11. Ahrendt SA, Chow JT, Yang SC, Wu L, Zhang MJ, Jen J, et al. Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer. Cancer Res. 2000; 60:3155-9.
12. Martini N, Flehinger BJ, Zaman MB, Beattie EF Jr. Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases. Ann Surg. 1983;198:386-97.
13. Sidransky D, Von Eschenbach A, Tsai YC, Jones P, Summerhayes I, Marshall F, et al. Identification of p53 gene mutations in bladder cancers and urine samples. Science. 1991;252:706-9.
14. Buchman GW, Schester DM, Raschtchas A. Rapid and efficient cloning of PCR products using the clone amp system. Focus. 1992; 14:41-5.
15. Maruyama R, Sugio K, Fukuyama Y, Hamatake M, Sakada T, Saitoh G, et al. Evaluation of p53 alterations in occult lymph node metastases. J Surg Oncol. 2000;73:143-7.
16. Passlick B, Kubuschok B, Izbicki JR, Thetter O, Pantel K. Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer. Ann Thorac Surg. 1999;68:2053-8.
17. Pantel K, Izbicki JR, Angstwurm M, Braun S, Passlick B, Karg O, et al. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer. Cancer Res. 1993;53:1027-31.
18. Pantel K, Izbicki J, Passlick B, Angstwurm M, Haussinger K, Thetter O, et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet. 1996;347:649-53.
19. Cote RJ, Beattie EJ, Chaiwun B, Shi SR, Harvey J, Chen SC, et al. Detection of occult bone marrow micrometastases in patients with operable lung carcinoma. Ann Surg. 1995;222:415-25.
20. Ohgami A, Mitsudomi T, Sugio K, Tsuda T, Oyama T, Nishida K, et al. Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancer. Ann Thorac Surg. 1997;64:363-7.
21. Zippelius A, Kufer P, Honold G, Kollermann MW, Oberneder R, Schlimok G, et al. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol. 1997;15:2701-8.
22. Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R, et al. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol. 1998;16:2632-40.
23. Cote RJ, Hawes D, Chaiwun B, Beattie EJ. Detection of occult metastases in lung carcinomas: progress and implications for lung cancer staging. J Surg Oncol. 1998;69:265-74.
24. Mitsudomi T, Oyama T, Kusano T, Osaki T, Nakanishi R, Shirakusa T. Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer. J Natl Cancer Inst. 1993; 85:2018-23.
25. Ahrendt SA, Chow JT, Xu LH, Yang SC, Eisenberger CF, Esteller M, et al. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J Natl Cancer Inst. 1999;91:332-9.
26. Brown HM, Ahrendt SA, Komorowski RK, Doffek K, Wilson SD, Demeure MJ. Immunohistochemistry and molecular detection of nodal metastases in pancreatic cancer. J Surg Res. 2001;95:141-6.
27. Keller SM, Adak S, Wagner H, Johnson DH. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group. Ann Thorac Surg. 2000;70:358-66.
28. Izbicki JR, Passlick B, Pantel K, Pichlmeier U, Hosch SB, Karg O, et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial. Ann Surg. 1998;227:138-44.
29. Liptay MJ, Masters GA, Winchester DJ, Edelman BL, Garrido BJ, Hirschtritt TR, et al. Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer. Ann Thorac Surg. 2000; 70:384-9.